Development of an effective treatment program for childhood acute lymphocytic leukemia: a preliminary report.

The development of an effective therapeutic regimen for acute lymphocytic leukemia (ALL) of childhood is described. By careful surveillance of toxicity and efficacy, positive modifications of treatment strategy were achieved without resorting to classically randomized trails. Teh resultant protocol utilizes vincristine-prednisone induction followed by asparaginase consolidation, intensive intermittent combination maintenance chemotherapy with adriamycin as a major component, and cranial radiotherapy plus intrathecal methotrexate for central nervous system prophylaxis. Preliminary analysis suggests that this regimen may result in prolonged continuous complete remission in at least 80% of children with ALL.

[1]  S. Balcerzak,et al.  Adriamycin cardiotoxicity in man. , 1974, Annals of internal medicine.

[2]  E. Hersh,et al.  Immunodiagnosis of acute leukemia: detection of residual disease. , 1974, Journal of the National Cancer Institute.

[3]  J. Burchenal,et al.  Intensive chemotherapy in children with acute lymphoblastic leukemia (L‐2 protocol) , 1974, Cancer.

[4]  J. Halazun,et al.  Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia , 1974 .

[5]  S K Carter,et al.  Adriamycin. A new anticancer drug with significant clinical activity. , 1974, Annals of internal medicine.

[6]  E. Gehan,et al.  Non-randomized controls in cancer clinical trials. , 1974, The New England journal of medicine.

[7]  J. Simone.  Acute lymphocytic leukemia in childhood. , 1974, Seminars in hematology.

[8]  V. Oliverio,et al.  The effects of antibiotics and cancer chemotherapeutic agents on the cellular transport and antitumor activity of methotrexate in L1210 murine leukemia. , 1973, Cancer research.

[9]  R. Price,et al.  The central nervous system in childhood leukemia: I. The arachnoid , 1973, Cancer.

[10]  J. Holland,et al.  Oncologists' reply: survival expectancy in acute lymphocytic leukemia. , 1972, The New England journal of medicine.

[11]  R. Webster,et al.  Immunologic rebound after cessation of long-term chemotherapy in acute leukemia. , 1972, Blood.

[12]  W. Johnson,et al.  Fatalities during remission of childhood leukemia. , 1972, Blood.

[13]  E. Gehan,et al.  Remission maintenance therapy for meningeal leukemia: intrathecal methotrexate vs. intravenous bis-nitrosourea. , 1971, Blood.

[14]  F. Burnet.  The concept of immunological surveillance. , 1970, Progress in experimental tumor research.

[15]  Y. S. Sathe,et al.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. , 1966, Annals of internal medicine.

[16]  D. Rall,et al.  Subarachnoid distribution of drugs after lumbar injection. , 1962, The New England journal of medicine.